Jeff Sampson

Jeff Sampson is a seasoned sales leader with extensive experience in the pharmaceutical industry, currently serving as a Senior District Sales Manager at Daiichi Sankyo, Inc. since October 2023. Prior to this role, Jeff was the National Clinical Network Director at Priovant Therapeutics, where the focus was on identifying clinical trial sites for a Dermatomyositis study. Jeff's career includes significant positions with AstraZeneca, where expansion efforts for Fasenra were led across the Midwest, and Takeda Oncology, where the launch of Alunbrig was managed for a broad region. Previously, Jeff excelled as a Regional Account Manager at ARIAD Pharmaceuticals, achieving national goal attainment, and at Alexion Pharmaceuticals, where the launch of Eculizumab for a rare disease was conducted. Jeff's early career includes impactful roles at Novartis and Pharmacia. Educational qualifications include a Master's degree in Management from Indiana Wesleyan University and a Bachelor's degree in Chemistry/Mathematics from Kentucky Wesleyan College.